Loss of Hdac3 in osteoprogenitors increases bone expression of osteoprotegerin, improving systemic insulin

Meghan E McGee-Lawrence1,2, Jessica L Pierce1, Kanglun Yu1

  • 1Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, Georgia.

Insights

Bone epigenetics regulate insulin sensitivity. Deleting Hdac3 in bone cells boosts osteoprotegerin (Opg), preventing type 2 diabetes and insulin resistance. This discovery offers new therapeutic avenues.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Bone Biology

Background:

  • Type 2 diabetes is a growing global health concern.
  • Understanding inter-system communication is key to developing new therapies.
  • Bone-derived factors influencing liver signaling may impact insulin resistance.

Purpose of the Study:

  • To investigate the role of the epigenetic regulator Hdac3 in osteoprogenitors.
  • To determine if Hdac3 deletion in bone cells affects diet-induced insulin resistance.
  • To elucidate the mechanism by which bone influences systemic insulin sensitivity.

Main Methods:

  • Utilized genetically modified mice with Hdac3 deletion in Osx1-expressing osteoprogenitors.
  • Administered a high-fat diet to induce insulin resistance.
  • Measured serum and skeletal gene expression of osteoprotegerin (Opg).
  • Assessed insulin sensitivity in Hdac3-deficient mice and controls.
  • Investigated the effect of the HDAC inhibitor vorinostat on Opg expression.

Main Results:

  • Hdac3 deletion in osteoprogenitors prevented high-fat diet-induced insulin resistance.
  • This protective effect was mediated by increased serum and skeletal Opg levels.
  • Reducing Opg levels in Hdac3-deficient mice exacerbated insulin resistance.
  • The HDAC inhibitor vorinostat increased Opg transcription and histone acetylation at the Opg locus.

Conclusions:

  • Hdac3 in osteoprogenitors plays a critical role in regulating systemic insulin sensitivity.
  • Bone-derived Opg is a key mediator linking Hdac3 activity in bone to metabolic homeostasis.
  • Targeting bone epigenetics, specifically Hdac3 and Opg, presents a novel therapeutic strategy for type 2 diabetes.

Related Concept Videos

Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.3K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.8K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.0K